Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

Erika Diaz v. Bayer Corporation

IN THE SUPREME COURT OF PENNSYLVANIA EASTERN DISTRICT


February 1, 2012

ERIKA DIAZ, RESPONDENT
v.
BAYER CORPORATION, BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS INC., F/K/A BERLEX, INC., F/K/A BERLEX LABORATORIES, INC. ON ITS OWN BEHALF AND AS SUCCESSOR BY MERGER TO BAYER PHARMACEUTICALS CORPORATION, AND BAYER PHARMA AG, F/K/A BAYER SCHERING PHARMA AG, PETITIONERS

Per curiam.

ORDER

AND NOW, this 1st day of February, 2012, as Petitioners' Amended Application for Exercise of King's Bench Powers or Extraordinary Jurisdiction replaced the initial Application for Exercise of King's Bench Powers or Extraordinary Jurisdiction, the initial Application for Exercise of King's Bench Powers or Extraordinary Jurisdiction is DISMISSED. Additionally, the Motion for Leave to File Reply Brief and the Motion for Leave to Supplement Application are GRANTED.

Furthermore, the Amended Application for Exercise of King's Bench Powers or Extraordinary Jurisdiction is DENIED.

Finally, the Motion for Consolidation is DISMISSED AS MOOT.

20120201

© 1992-2012 VersusLaw Inc.



Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.